As of 2024-12-14, the Relative Valuation of NGM Biopharmaceuticals Inc (NGM) is (15.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on Relative Valuation is -1074.8%.
The range of the Relative Valuation is (11.26) - (16.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 13.4x | 9.8x |
| Forward P/E multiples | 6.6x - 9.8x | 7.8x |
| Fair Price | (11.26) - (16.75) | (15.01) |
| Upside | -831.1% - -1187.8% | -1074.8% |
| Date | P/E |